...
首页> 外文期刊>Infectious diseases in clinical practice: IDCP >Retrospective Study of Prolonged Versus Intermittent Infusion Piperacillin-Tazobactam and Meropenem in Intensive Care Unit Patients at an Academic Medical Center
【24h】

Retrospective Study of Prolonged Versus Intermittent Infusion Piperacillin-Tazobactam and Meropenem in Intensive Care Unit Patients at an Academic Medical Center

机译:在学术医学中心对重症监护病房患者进行长期与间歇输注哌拉西林-他唑巴坦和美罗培南的回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Prolonged infusions of beta-lactams are increasingly being utilized because of increased antimicrobial resistance and a lack of new antibiotics in the pipeline.Methods: A retrospective, observational study evaluated adult patients who received at least 72 hours of piperacillin-tazobactam or meropenem in a medical and surgical intensive care unit (ICU) at an academic medical center. In the first 6 months of the study, all patients received conventional intermittent dosing; in the second 6 months, all patients received these antibiotics by prolonged infusions. The main outcome comparisons between groups were duration of ventilator support, duration of ICU and hospital length of stay, and in-hospital mortality.
机译:背景:由于抗生素耐药性的增强和正在使用的新抗生素的缺乏,越来越多地使用长时间输注β-内酰胺的方法。方法:一项回顾性观察性研究评估了接受过至少72小时哌拉西林-他唑巴坦或美罗培南治疗的成年患者。学术医学中心的医学和外科重症监护室(ICU)。在研究的前6个月中,所有患者均接受常规间歇给药;在接下来的6个月中,所有患者均通过长时间输注接受了这些抗生素。两组之间的主要结局比较是呼吸机支持的持续时间,ICU的持续时间和住院时间以及院内死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号